Extremities Cartiva Announces First Patient Enrolled in ProxiFuse Post Market Study byJosh SandbergSeptember 11, 2015
Extremities Cartiva Announces Positive Final Data from its Cartiva SCI Pivotal Trial for Great Toe Arthritis byJosh SandbergJuly 17, 2015
Financial Cartiva Inc. Just Filed Form D Announcing $8.50 million Financing byJosh SandbergApril 21, 2015
Extremities Cartiva Announces 510(k) Clearance for ProxiFuse Hammertoe Correction System byJosh SandbergJanuary 7, 2015
